grade/stage tissue microarray (tma) slides (BioResource International Inc)
90
Structured Review
BioResource International Inc
grade/stage tissue microarray (tma) slides
Grade/Stage Tissue Microarray (Tma) Slides, supplied by BioResource International Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+prostate+tissue+microarray+slides/tissue+microarray/ppr0377422-47-7-29
Average 90 stars, based on 1 article reviews
Grade/Stage Tissue Microarray (Tma) Slides, supplied by BioResource International Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+prostate+tissue+microarray+slides/tissue+microarray/ppr0377422-47-7-29
Average 90 stars, based on 1 article reviews
grade/stage tissue microarray (tma) slides - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
other:Article Title: Expression and Subcellular Localization of Discoidin Domain Receptor 1 (DDR1) Define Prostate Cancer Aggressiveness Article Snippet: Materials And Methods Article Title: Investigation of hormone receptor expression and its prognostic value in endometrial stromal sarcoma. Article Snippet: To evaluate the immunohistochemical (IHC) expression of hormone receptors and analyze the prognostic implication of these receptors in patients with endometrial stromal sarcoma (ESS).. Fifty-one patients with ESS whose paraffin blocks and pathologic slides, which were obtained after hysterectomy, were available and included in this study.. Clinicopathologic data were gathered from patients’medical records, and IHC staining of hormone receptors was performed using tissue microarrays. Article Title: ETS1 induces transforming growth factor β signaling and promotes epithelial-to-mesenchymal transition in prostate cancer cells. Article Snippet: Anatomical Pathology, PathWest Laboratory Medicine, Royal Perth Hospital, Perth, Western Australia, Australia* School of Pathology and Laboratory Medicine, University of Western Australia, Crawley, Western Australia, Australia Anatomical Pathology, PathWest Laboratory Medicine, Fiona Stanley Hospital, Murdoch, Western Australia, Australia Laboratory for Cancer Medicine, Harry Perkins Institute of Medical Research, Nedlands, Western Australia, Australia Uropath, West Leederville, Western Australia, Australia Centre for Medical Research and Medical School, University of Western Australia, Crawley, Western Australia, Australia Anatomical Pathology, PathWest Laboratory Medicine, QEII Medical Centre, Crawley, Western Australia, Australia Australian Prostate Cancer BioResource (APCB), Brisbane, Queensland, Australia Article Title: Temporary treatment cessation compared with continuation of tyrosine kinase inhibitors for adults with renal cancer: the STAR non-inferiority RCT Article Snippet: The samples were collected by the Microarray:Article Title: MesobanK UK: an international mesothelioma bioresource Article Snippet: MesobanK has been created to establish a bioresource of pleural mesothelioma tissue linked to detailed anonymised clinical data. .. When complete, the Article Title: Location of CD39 + T cell subpopulations within tumors predict differential outcomes in non-small cell lung cancer. Article Snippet: Tumor/non- cancerous lungNCL tissue and blood samples were obtained following approval by National Health Service (NHS) Lothian REC and facilitated by NHS Lothian SAHSC Bioresource (REC No: 15/ ES/0094), with informed consent from all patients. .. The tissue microarray (TMA) was approved NHS Lothian REC and facilitated by Article Title: A Novel Approach for the Discovery of Biomarkers of Radiotherapy Response in Breast Cancer Article Snippet: .. Ethical approval for use of tissue microarray samples from the Breast-Conserving Series was granted under the Article Title: Cancer-associated fibroblasts expressing fibroblast activation protein and podoplanin in non-small cell lung cancer predict poor clinical outcome Article Snippet: .. The tissue microarray was approved NHS Lothian REC and facilitated by |